Risks of Excessive Vitamin B6 Levels
Excessive vitamin B6 levels can cause sensory neuropathy with ataxia or areflexia, impaired cutaneous and deep sensations, and dermatologic lesions. 1
Neurological Toxicity
- Peripheral neuropathy is the primary manifestation of vitamin B6 toxicity, typically presenting with numbness/paresthesia in extremities, loss of distal sensation, motor ataxia, weakness, and loss of deep tendon reflexes 2
- Neurotoxicity can occur at various dosage levels:
- Established toxicity at doses ≥1000 mg/day (approximately 800 times the daily intake from foods) 3
- Reports of toxicity at intakes of 100-300 mg/day 3
- Recent evidence suggests toxicity may occur at much lower doses in some individuals, even with daily multivitamin use containing only 6 mg of vitamin B6 4
Muscle and Nerve Damage
- Elevated B6 levels can contribute to muscle atrophy through effects on peripheral nerves 2
- Animal studies show that vitamin B6 deficiency (and by extension, toxicity from B6 antagonists) can cause:
- Significant loss of neural tissue
- Reduction in nerve conduction velocity
- Widespread muscle atrophy
- Extensive myelin disruption
- Fragmentation of intramuscular nerve fibers 1
Safe Levels and Recommendations
- The US authorities have established:
- No-observed-adverse-effect-level at 200 mg/day
- Safe upper limit at 100 mg/day 3
- ESPEN guidelines indicate that negative effects have been related to prolonged intakes of 300 mg/day, with potential side effects at doses as low as 100 mg/day 1
- Long-term doses of 100 mg/day have been associated with Lhermitte signs (indicating spinal cord effects) 1
Monitoring and Prevention
- Plasma pyridoxal phosphate (PLP) levels should be used to determine vitamin B6 status:
- Adequate status: >30 nmol/L (7.4 μg/L)
- Risk of toxicity: >100 nmol/L (25 μg/L) 5
- In cases of inflammation or serious illness, red cell PLP should be measured instead of plasma levels 1
- PLP-based supplements are preferred over pyridoxine supplements due to minimal neurotoxicity observed in neuronal cell viability tests 5
- Weekly administration (50-100 mg) is preferred over daily use to prevent toxicity due to the long half-life of B6 metabolites 5
Special Populations at Risk
- Patients with impaired renal function have reduced ability to clear vitamin B6 metabolites, leading to potential elevation 2
- Bariatric surgery patients are at particular risk due to routine supplementation practices:
- Elderly individuals may be more susceptible to B6 accumulation due to age-related changes in metabolism 2
Recovery from Toxicity
- A washout period of 20-40 days is typically required for complete clearance of vitamin B6 7
- Some nerve damage may persist even after discontinuation of excessive vitamin B6 intake, as demonstrated in animal studies 1
Clinical Approach to Suspected B6 Toxicity
- Review all medications and supplements for potential vitamin B6 content or interactions 2
- Measure plasma PLP levels to confirm elevated B6 status 1
- Discontinue all sources of supplemental vitamin B6 if levels are elevated 7
- Monitor for improvement in neurological symptoms, which may take several weeks to months to resolve 1